Target intelligence / Profile preview

Crystallin (lens protein)

Molecular classification
Other, Structural protein
01

Overview

Crystallins are the major structural proteins of the vertebrate eye lens, essential for its transparency and refractive properties[4][2][9]. There are three main types: α-crystallin (a small heat shock protein with chaperone activity), β-crystallin, and γ-crystallin (both predominantly structural)[2][7][9]. Within these proteins, disulfide bonds—covalent links between sulfur atoms of cysteine residues—play a crucial role in stabilizing protein structure[1][3][5]. Recent research indicates that disulfide bonds can form during protein biosynthesis, not just as a post-translational modification[1]. In the aging lens or under oxidative stress, abnormal disulfide bonding can occur, leading to aggregation of damaged crystallin proteins, loss of transparency, and cataract formation—the most common cause of human blindness worldwide[3][5]. Dynamic disulfide exchange in crystallins, especially in γ-crystallins, is a critical contributor to this process[3][5][7]. Unlike canonical drug targets, **disulfide bonds** are not molecular entities but structural features, and so are not classifiable as therapeutic targets (e.g., receptor, enzyme, transporter). Experimental therapies may attempt to modulate crystallin aggregation by interfering with disulfide exchange or stabilizing crystallin structure, but no drugs directly target these bonds to date[3].

Other names
lens crystallineye-lens crystallinα-crystallinβ-crystallinγ-crystallin
02

Biological functions

Maintenance of lens transparencyRefraction of lightProtein homeostasis/chaperone activity (specifically α-crystallin)
03

Disease associations

Cataract (lens opacities)Age-related aggregation

Beyond the preview

Go deeper on Crystallin (lens protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crystallin (lens protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call